Ipilimumab vs Propranolol
Ipilimumab vs Propranolol: Overview
This comparison examines the pharmacological differences between Ipilimumab and Propranolol.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Propranolol: Non-selective beta-adrenergic receptor blocker.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Propranolol — 3-6 hours.
Chemical Properties
Molecular Formula: Propranolol — C16H21NO2.
Molecular Weight: Propranolol — 259.3440 g/mol.
Type: Ipilimumab — Antibody; Propranolol — Small molecule.